Tag: AHA 2024
AHA 2024: Five-year Amulet IDE data show similar outcomes with Amplatzer and Watchman devices
Latest data from the ...
AHA 2024: OPTION trial reports positive outcomes for Watchman FLX at three years after AF ablation
Three-year results fr...
AHA 2024: Edoxaban an “effective alternative” to warfarin following valve replacement surgery
Edoxaban may be an effect...
